Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Abera Bioscience | ABERA | 30. avr 2024 | 4.71 | -1.26 |
Abliva | ABLI | 30. avr 2024 | 0.17 | +1.18 |
Active Biotech | ACTI | 30. avr 2024 | 0.56 | +1.82 |
AcuCort | ACUC | 30. avr 2024 | 0.52 | -3.70 |
Aegirbio | AEGIR | 30. avr 2024 | 0.49 | -1.01 |
Alligator Bioscience | ATORX | 30. avr 2024 | 0.90 | -2.70 |
AlzeCure Pharma | ALZCUR | 30. avr 2024 | 1.89 | -1.56 |
Alzinova | ALZ | 30. avr 2024 | 1.12 | -3.78 |
Amniotics | AMNI | 30. avr 2024 | 0.00 | +2.63 |
Annexin Pharmaceuticals | ANNX | 30. avr 2024 | 0.30 | +5.26 |
Aptahem | APTA | 30. avr 2024 | 0.03 | +0.66 |
Arcede Pharma AB | ARCEDE | 30. avr 2024 | 0.10 | +1.04 |
AroCell | AROC | 30. avr 2024 | 0.40 | +6.17 |
Asarina Pharma | ASAP | 30. avr 2024 | 0.97 | -1.22 |
Ascelia Pharma | ACE | 30. avr 2024 | 10.58 | -0.56 |
AstraZeneca | AZN | 30. avr 2024 | 1 671.50 | +0.97 |
Attana | ATANA | 30. avr 2024 | 0.08 | +12.50 |
Bio-Works Technologies | BIOWKS | 30. avr 2024 | 2.94 | 0.00 |
BioArctic B | BIOAB | 30. avr 2024 | 195.00 | -2.01 |
BioGaia B | BIOGB | 30. avr 2024 | 117.90 | +1.20 |
BioInvent International | BINV | 30. avr 2024 | 26.00 | +2.77 |
Biosergen | BIOSGN | 30. avr 2024 | 0.33 | 0.00 |
Biovica International B | BIOVICB | 30. avr 2024 | 1.59 | -0.25 |
Calliditas Therapeutics | CALTX | 30. avr 2024 | 110.00 | +2.90 |
Camurus | CAMX | 30. avr 2024 | 498.20 | +0.36 |
Cantargia | CANTA | 30. avr 2024 | 3.34 | -2.74 |
Cereno Scientific B | CRNOB | 30. avr 2024 | 3.85 | -2.23 |
Chordate Medical Holding | CMH | 30. avr 2024 | 0.06 | +6.32 |
Chosa Oncology AB | CHOSA | 30. avr 2024 | 1.00 | -0.20 |
Cline Scientific B | CLINEB | 30. avr 2024 | 0.14 | -14.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.